Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
201.20    -1.40 (-0.69%)
Bid:
201.20
Ask:
201.80
Spread: 0.60 (0.298%)
Market Cap: £1.31b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Directorate Change

21 Mar 2022 16:30

RNS Number : 4616F
Ashmore Group PLC
21 March 2022
 

 

Ashmore Group plc

21 March 2022

 

DIRECTORATE CHANGE

 

Ashmore Group plc ("Ashmore" / the "Company") today announces that after more than seven years' service on the Board of Directors (the "Board") of Ashmore, including over three years as Chair, David Bennett will be stepping down both as a Non-Executive Director and Chair of the Company on 20 April 2022. The Board would like to take this opportunity to thank David for his significant contribution during his tenure.

 

After due consideration, the Nominations Committee has concluded that Clive Adamson, who has served as a Non-Executive Director since 2015 and is currently the Senior Independent Director, will succeed David as Chair of the Company and Chair of its Nominations Committee, in addition to continuing as Chair of the Audit and Risk Committee, from 21 April 2022.

 

The appointment of Clive as Chair of the Nominations Committee is subject to regulatory approval from the Financial Conduct Authority. Ashmore is in the process of identifying a successor to assume the role of Chair of the Audit and Risk Committee in order to ensure compliance with the UK Corporate Governance Code.

 

As a consequence of these changes, the structure of the Board Committees with effect from 21 April 2022 will be as follows:

 

Audit and Risk

Remuneration

Nominations

Clive Adamson (Interim Chair)

Helen Beck (Chair)

Clive Adamson (Chair)

Helen Beck

Clive Adamson

Helen Beck

Jennifer Bingham

Jennifer Bingham

Jennifer Bingham

 

Ashmore also announces that Jennifer Bingham will assume the role of Senior Independent Director from 21 April 2022 and Clive will step down from this role with effect from the same date.

 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plc

Paul Measday

Investor Relations +44 (0)20 3077 6278

 

FTI Consulting

Neil Doyle +44 (0)7771 978 220

Kit Dunford +44 (0) 7717 417 038

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFLFLLXLEBBK
Date   Source Headline
16th Sep 20204:09 pmRNS2020 Annual Financial Report and Notice of AGM
11th Sep 20207:00 amRNSFinal Results
14th Jul 20207:00 amRNSTrading Statement
23rd Jun 20205:40 pmRNSDirector/PDMR Shareholding
19th Jun 20206:07 pmRNSDirector/PDMR Shareholding
19th Jun 20206:04 pmRNSHolding(s) in Company
27th Apr 20203:33 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:44 pmRNS2019 AGM voting result update statement
1st Apr 20209:51 amRNSDirector/PDMR Shareholding
16th Mar 20203:29 pmRNSHolding(s) in Company
13th Mar 20206:21 pmRNSDirector/PDMR Shareholding
7th Feb 20204:50 pmRNSDirector/PDMR Shareholding
7th Feb 20204:49 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSHalf-year Report
15th Jan 20207:00 amRNSTrading Statement
10th Dec 20199:16 amRNSDirector/PDMR Shareholding
9th Dec 20192:08 pmRNSDirector/PDMR Shareholding
11th Nov 201912:17 pmRNSDirector/PDMR Shareholding
21st Oct 201911:42 amRNSDirector Declaration
18th Oct 20193:32 pmRNSResult of AGM
16th Oct 20191:08 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSTrading Statement
30th Sep 20195:38 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSDirector/PDMR Shareholding
18th Sep 201912:04 pmRNSDirector/PDMR Shareholding
18th Sep 201912:01 pmRNSDirector/PDMR Shareholding
16th Sep 20192:07 pmRNS2019 Annual Report and Notice of AGM
6th Sep 20197:00 amRNSFinal Results
12th Jul 20197:00 amRNSTrading Statement
18th Apr 20195:08 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSTrading Statement
5th Apr 20198:57 amRNSDirector/PDMR Shareholding
3rd Apr 20194:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:30 pmRNSHolding(s) in Company
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSTrading Statement
10th Dec 20182:14 pmRNSDirector/PDMR Shareholding
19th Oct 20185:08 pmRNSResult of AGM
12th Oct 20187:00 amRNSTrading Statement
1st Oct 20188:13 amRNSTotal Voting Rights
18th Sep 20186:04 pmRNSDirector/PDMR Shareholding
18th Sep 20186:00 pmRNSDirector/PDMR Shareholding
13th Sep 20184:16 pmRNSHolding(s) in Company
13th Sep 20184:11 pmRNSNotice of AGM
11th Sep 20185:19 pmRNSHolding(s) in Company
11th Sep 20185:04 pmRNSTreasury Shares
7th Sep 20187:00 amRNSFinal Results
6th Sep 20181:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.